Adalimumab

Details

Files
Generic Name:
Adalimumab
Project Status:
Complete
Therapeutic Area:
Hidradenitis suppurativa
Manufacturer:
AbbVie Corporation
Call for patient/clinician input open:
Brand Name:
Humira
Project Line:
Reimbursement Review
Project Number:
SR0455-000
Call for patient/clinician input closed:
NOC Status at Filing:
Pre NOC
Performance Metric:
Achieved
Submission Type:
Initial
Indications:
Hidradenitis suppurativa
Recommendation Type:
Reimburse with clinical criteria and/or conditions
Final Recommendation: